Watsco
WSO
282.65
-8.18
-2.81%
Watsco
US · WSO
#1278 by market cap
Listed 1970
282.65
-8.18
-2.81%
Live - 5344 symbols - heartbeat 104s ago
· 2026-10-08 08:37
Pre-market
281.00
-0.58%
After-hours
282.65
0.00%
- Market cap
- 11.66B
- P/E (TTM)i
- 24.22
- P/Bi
- 3.89
- EPSi
- 12.25
- Div yieldi
- 4.35%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on WSO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.05, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -4.98% YoY
Margins
- Gross margin
- 28.05%
- Operating margin
- 9.57%
- Net margin
- 6.41%
Key ratios & quality
- Altman Z-Scorei
- 9.05
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.55B | 4.77B | 5.05B | 6.28B | 7.27B | 7.28B | 7.62B | 7.24B |
| Gross profit | 1.12B | 1.16B | 1.22B | 1.67B | 2.03B | 1.99B | 2.04B | 2.03B |
| Selling & admin expenses | 757.45M | 800.33M | 833.05M | 1.06B | 1.22B | 1.22B | 1.29B | 1.34B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 362.80M | 356.63M | 389.77M | 609.23M | 808.91M | 768.63M | 751.27M | 692.58M |
| Pretax profit | 369.34M | 362.85M | 399.80M | 627.53M | 829.41M | 789.89M | 802.64M | 737.68M |
| Tax | 72.81M | 67.08M | 76.62M | 128.80M | 125.72M | 155.75M | 166.90M | 150.09M |
| Net profit | 296.53M | 295.78M | 323.17M | 498.74M | 703.70M | 634.14M | 635.74M | 587.59M |
| Basic EPS | 7 | 7 | 7 | 11 | 15 | 14 | 13 | 12 |
| Diluted EPS | 6.49 | 6.50 | 7.01 | 10.78 | 15.41 | 13.67 | 13.30 | 12.25 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.53B | 2.06B | 2.07B | 1.58B | 1.53B | 2.10B |
| Gross profit | 429.62M | 603.49M | 568.92M | 428.44M | 427.56M | 578.93M |
| Selling & admin expenses | 322.58M | 339.00M | 343.66M | 332.65M | 322.85M | 348.99M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 107.04M | 271.87M | 225.26M | 95.79M | 104.70M | 238.37M |
| Pretax profit | 117.61M | 274.20M | 238.50M | 107.38M | 116.64M | 241.87M |
| Tax | 23.07M | 57.43M | 49.27M | 20.33M | 23.70M | 50.57M |
| Net profit | 94.54M | 216.77M | 189.23M | 87.05M | 92.94M | 191.30M |
| Basic EPS | 2 | 5 | 4 | 2 | 2 | 4 |
| Diluted EPS | 1.93 | 4.52 | 3.98 | 1.57 | 1.87 | 4.00 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.44B | 1.55B | 1.48B | 1.96B | 2.30B | 2.39B | 3.08B | 2.95B |
| Cash & ST investments | 82.89M | 74.45M | 146.07M | 118.27M | 147.51M | 210.11M | 781.94M | 733.28M |
| Inventory | 837.13M | 920.79M | 781.30M | 1.12B | 1.37B | 1.35B | 1.39B | 1.39B |
| Total assets | 2.16B | 2.56B | 2.48B | 3.09B | 3.49B | 3.73B | 4.48B | 4.41B |
| Total current liabilities | 357.57M | 461.72M | 487.15M | 726.72M | 906.52M | 712.01M | 983.90M | 717.74M |
| Short-term debt | 246.00K | 69.42M | 71.80M | 84.50M | 147.00M | 100.27M | 110.27M | 117.15M |
| Long-term debt | 135.75M | 155.70M | -- | 89.00M | -- | 15.40M | -- | -- |
| Total liabilities | 559,320,000.00 | 841,394,000.00 | 704,586,000.00 | 1,088,446,000.00 | 1,239,936,000.00 | 1,112,992,000.00 | 1,415,285,000.00 | 1,192,744,000.00 |
| Total equity | 1.60B | 1.71B | 1.78B | 2.00B | 2.25B | 2.62B | 3.06B | 3.22B |
| Retained earnings | 627.97M | 632.51M | 636.37M | 760.80M | 1.03B | 1.18B | 1.30B | 1.32B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.04B | 3.30B | 3.12B | 2.95B | 3.18B | 3.45B |
| Cash & ST investments | 431.82M | 292.98M | 524.35M | 733.28M | 592.68M | 464.19M |
| Inventory | 1.78B | 1.95B | 1.60B | 1.39B | 1.72B | 1.89B |
| Total assets | 4.45B | 4.73B | 4.55B | 4.41B | 4.65B | 5.08B |
| Total current liabilities | 925.14M | 1.07B | 812.14M | 717.74M | 951.87M | 1.08B |
| Short-term debt | 113.32M | 115.42M | 116.70M | 117.15M | 117.71M | 119.72M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,366,493,000.00 | 1,507,694,000.00 | 1,253,073,000.00 | 1,192,744,000.00 | 1,434,577,000.00 | 1,611,507,000.00 |
| Total equity | 3.09B | 3.22B | 3.30B | 3.22B | 3.21B | 3.47B |
| Retained earnings | 1.27B | 1.33B | 1.37B | 1.32B | 1.28B | 1.31B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 170.56M | 335.77M | 534.38M | 349.57M | 571.96M | 561.95M | 773.10M | 569.61M |
| Depreciation & amortization | 22.10M | 24.51M | 25.91M | 28.13M | 31.68M | 35.09M | 40.82M | 43.75M |
| Free cash flow | 153.40M | 317.97M | 517.94M | 324.10M | 536.31M | 526.48M | 743.01M | 535.06M |
| Dividends paid | -209.22M | -241.41M | -265.71M | -294.52M | -332.45M | -382.65M | -423.52M | -473.77M |
| Stock buybacks / issuance | 2.81M | 11.81M | 16.96M | 19.92M | -87.11M | 12.35M | 242.11M | -3.66M |
| Ending cash balance | 82.89M | 74.45M | 146.07M | 118.27M | 147.51M | 210.11M | 526.27M | 433.28M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -177.64M | -7.45M | 354.94M | 399.77M | -18.91M | -2.54M |
| Depreciation & amortization | 10.78M | 10.91M | 10.99M | 11.07M | 11.02M | 10.92M |
| Free cash flow | -185.19M | -14.28M | 346.06M | 388.47M | -25.87M | -11.52M |
| Dividends paid | -109.04M | -121.46M | -121.59M | -121.68M | -121.78M | -134.15M |
| Stock buybacks / issuance | 11.05M | -11.05M | -3.66M | 0 | 5.17M | -6.58M |
| Ending cash balance | 431.82M | 292.98M | 324.35M | 433.28M | 392.68M | 364.19M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.87 | 16.21 | 16.87 | 24.22 | 30.94 | 24.25 | 20.42 | 17.07 |
| ROA %i | 10.61 | 9.56 | 9.78 | 13.70 | 16.73 | 13.84 | 12.16 | 10.44 |
| ROIC %i | 16.07 | 13.87 | 14.06 | 20.47 | 25.57 | 20.48 | 17.39 | 14.59 |
| 5-year avg ROE %i | 17.38 | 17.11 | 16.72 | 18.15 | 21.02 | 22.50 | 23.34 | 23.38 |
| EBIT margin %i | 8.18 | 7.69 | 7.93 | 10.01 | 11.43 | 10.91 | 9.86 | 9.57 |
| FCF / sales %i | 3.37 | 6.67 | 10.25 | 5.16 | 7.37 | 7.23 | 9.75 | 7.39 |
| Current ratioi | 4.03 | 3.35 | 3.05 | 2.70 | 2.54 | 3.36 | 3.13 | 4.12 |
| Quick ratioi | 1.64 | 1.32 | 1.40 | 1.12 | 0.99 | 1.42 | 1.69 | 2.13 |
| Debt / assetsi | 6.29 | 14.92 | 8.70 | 11.98 | 11.20 | 10.85 | 9.99 | 10.85 |
| LT debt / equityi | 10.07 | 21.73 | 9.71 | 17.13 | 12.89 | 13.66 | 12.69 | 13.00 |
| Interest coveragei | 135.80 | 90.99 | 323.68 | 631.05 | 384.10 | 161.55 | -- | -- |
| Revenue CAGR (3Y) %i | 3.40 | 4.17 | 5.20 | 11.37 | 15.10 | 12.95 | 6.65 | -0.16 |
| Net income CAGR (3Y) %i | 12.00 | 10.39 | 8.99 | 19.92 | 34.70 | 25.77 | 8.58 | -6.15 |
| FCF CAGR (3Y) %i | -8.33 | 10.11 | 21.52 | 28.32 | 19.04 | 0.55 | 31.86 | -0.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.94 | 18.45 | 17.68 | 17.07 | 17.04 | 15.41 |
| ROA %i | 11.16 | 10.86 | 10.74 | 10.44 | 10.16 | 9.04 |
| ROIC %i | 16.22 | 15.89 | 15.23 | 14.59 | 14.51 | 13.15 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.72 | 9.86 | 9.80 | 9.57 | 9.53 | 9.02 |
| FCF / sales %i | 6.06 | 5.25 | 6.98 | 7.39 | 9.59 | 9.57 |
| Current ratioi | 3.28 | 3.08 | 3.84 | 4.12 | 3.34 | 3.20 |
| Quick ratioi | 1.33 | 1.22 | 1.81 | 2.13 | 1.50 | 1.41 |
| Debt / assetsi | 10.32 | 9.60 | 10.04 | 10.85 | 10.46 | 10.53 |
| LT debt / equityi | 13.00 | 12.27 | 12.11 | 13.00 | 13.34 | 13.88 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Air conditioning, heating, and refrigeration (HVAC) equipment is the largest reported line at 68.00% of revenue, across 3 reported segments.
- Other air conditioning, heating, and refrigeration (HVAC) products follows at 28.00%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Air conditioning, heating, and refrigeration (HVAC) equipment68.00%
Other air conditioning, heating, and refrigeration (HVAC) products28.00%
Commercial refrigeration products4.00%
Quote time 2026-10-08 08:37:59 · For reference only, not investment advice and not tailored to your situation.